Firm files PMA for its automated, qualitative hepatitis B diagnostic, which detects antibodies to the hepatitis B virus core antigen. The test is run on the firm's Architect laboratory immunoassay analyzer. Abbott cites CDC statistics indicating that 1.25 million people in the U.S. have chronic hepatitis B
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
